Login

Tag: IQVIA

IQVIA

Courts/First Amendment

CHC brief questions FTC ad market definition in IQVIA merger challenge

CHC brief questions FTC ad market definition in IQVIA merger challenge

WASHINGTON, DC – The Coalition for Healthcare Communication (CHC) has filed a federal court amicus brief that raises concerns about how the Federal Trade Commission (FTC) defined the “programmatic advertising” marketplace in its complaint against IQVIA’s proposed merger with Propel Media and offered its real-world insight into the industry, which span the entire digital “ad […]

Read more

Drug Pricing

IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation

IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation

April 25, 2022 – With drug pricing a hot-button issue as the midterm elections draw near, a recent report from the IQVIA Institute for Human Data Science shines a spotlight on some of the nuances that often are missed when discussing the nuts and bolts of drug spending in the United States. One of the […]

Read more

Categories

Recent Posts

Tags

ACA ad tax CDER chc CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy data privacy legislation DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media FTC gifts to physicians HHS Jim Potter John Kamp Jon Bigelow kamp Kate Rawson legislation litigation off-label off-label communication OPDP OPDP enforcement PhRMA regulation rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines